Drugs in the Therapy of Angina - PowerPoint PPT Presentation

1 / 11
About This Presentation
Title:

Drugs in the Therapy of Angina

Description:

Title: PowerPoint Presentation Author: Campbell University Last modified by: Campbell University Created Date: 11/2/2000 2:05:46 PM Document presentation format – PowerPoint PPT presentation

Number of Views:108
Avg rating:3.0/5.0
Slides: 12
Provided by: CampbellU7
Category:

less

Transcript and Presenter's Notes

Title: Drugs in the Therapy of Angina


1
Drugs in the Therapy of Angina
Dr. Thomas Abraham PHAR417 Fall 2004
2
Regulation of vascular smooth muscle
contractility by Nitric oxide
  •    Acetylcholine (via M2/M3 receptors) and
    bradykinin (via B1/B2 receptors) causes
    endothelial cells on arteries and veins to
    release nitric oxide (NO).
  •  
  •  
  •  
  • Released NO travels through the wall of the
    blood vessel to reach the smooth muscle cells to
    initiate biological response.
  •     NO binds and activates cytosolic guanylate
    cyclase, which converts GTP to cGMP.

3
Role of Nitric Oxide In Vascular smooth muscle
relaxation.
  •    The overall effect of the cGMP-PKG system is
    to cause smooth muscle relaxation by decreasing
    intracellular calcium levels to decrease
    actin-myosin interactions
  • -         phosphorylates and inactivate PLC and
    the IP3 channel.
  •   decreased production of IP3 and decreased
    effectiveness of IP3 to release calcium from SR
    stores.
  •   -         activate the SR Ca2-ATPase.
  •   increased rate of removal of calcium from the
    cytoplasm.
  •    Organic nitrates mimic the effects of NO to
    cause smooth muscle relaxation.

4
Pathophysiology of Angina
  •     Angina pectoris is caused by accumulation of
    metabolic byproducts in myocardial tissue and
    results because oxygen demand by the myocardium
    far exceeds the oxygen (blood) supply.
  •  
  •  
  •      Oxygen supply and demand mismatch are
    primarily due to atherosclerotic occlusion of
    coronary arteries (exertional, stable angina).
    Angiospasms (variant angina) is also responsible
    for cardiac ischemia.
  •  
  •  
  •  
  •       Theoretically the supply to demand mismatch
    can be corrected by
  • -         improving blood flow to the myocardium
  •  
  •  
  • -         decreasing myocardial oxygen demand

5
Nitrate vasodilators in Angina Therapy
  •       Are polyol organic esters of nitric acid
  • - the nitrate esters (R-- CONO2)
  • - the nitrite esters (RCONO)
  •  
  •       Amyl nitrite is volatile administered as
    a gas.

6
Nitrate vasodilators in Angina Therapy
  •      Fully nitrated polyols are non-polar and
    lipid soluble allows rapid absorption from
    inhalational, dermal and sublingual sites.
  • -         NTG sublingual, transdermal (patch and
    ointment), spray
  • -         Amyl nitrite inhalational
  • -         Isosorbide dinitrate sublingual,
    chewable
  •  
  •      Degradation of the nitrates in the presence
    of glutathione generates the NO free radical,
    which causes vasodilation.
  • Greater potency of erythrityl tetranitrate and
    nitroglyerin relative to other organic nitrates
    may be due to more rapid bioactivation.

7
Nitrate vasodilators in Angina Therapy
  •     Rapid onset of action after sublingual admin.
    due to by-pass of liver first time through.
    Sublingual administration in acute attacks and
    prophylaxis of acute attacks.
  •     Oral administration of nitrates has longer
    onset time but longer duration of action.
  •  
  •     Transdermal delivery (NTG patch) onset time
    of 1hour and duration of 4-8 hours.
  •  
  •      Tolerance to all nitrate compounds develops
    after prolonged use and treatment has to be
    interrupted every 8 hours.
  • Tolerance may be due to decreased production
    of NO from nitrate drugs or due to the production
    of oxygen free radicals (O2-) which react with
    NO to form peroxynitrates that are not
    vasodilators.

8
Nitrate vasodilators in Angina Therapy
  •     Nitrates dilate veins preferentially over
    arteries leading to decreased left and right
    heart end-diastolic pressure (decreased preload)
    with small change in TPR.
  • -          heart rate unchanged or slightly
    increased due baroreceptor reflex mechanism.
  • -          Cardiac output decreases due to lower
    ventricular end-diastolic pressure.
  •  
  •      Lower doses dilate arterial vessels of skin,
    meninges flushing, headache
  •  
  •       Higher doses (1) decrease systolic and
    diastolic pressure decrease TPR
  • (2) decrease C.O. (3) cause venous blood
    pooling (4) reflex sympathetic nerve activity.

9
Nitrate vasodilators in Angina Therapy
  •    Appear to alleviate anginal pain by restoring
    myocardial oxygen supply/demand via
  • -          decreasing myocardial work due to
    decreased afterload and preload.
  •  
  • -          Ischemic regions of heart may have
    improved blood flow to subendocardial regions
    due to decreased preload that decreases
    ventricular wall tension.
  •  
  •  
  •     Adverse effects (cardiovascular) headache,
    dizziness, weakness, postural hypotension,
    flushed skin, tachycardia, rash.

10
Nitrate vasodilators in Angina Therapy
Drug Interactions Nitrates are contraindicated in
patients on sildenafil (Viagra) due to increased
potential for hypotensive episode via PDE5
inhibition. Therapeutic Use Used in exertional
and variant angina to restore myocardial oxygen
supply/demand. Nitrates are used in congestive
heart failure Improve coronary blood flow after
MI
11
Other agents in Angina Therapy
b-blockers metoprolol, timolol, atenolol have
been shown effective in reducing anginal attacks
by decreasing myocardial oxygen
demand. Calcium-channel blockers amlodipine,
bepridil, nicardipine improve coronary blood flow
to increase myocardial oxygen supply
Write a Comment
User Comments (0)
About PowerShow.com